Neurology Updates
Atacicept increases clinical disease activity in relapsing multiple sclerosis
Depletion of B lymphocytes is associated with suppression of inflammatory activity in multiple sclerosis. A study has assessed the safety and efficacy of Atacicept, a recombinant fusion protein that suppresses B-cell function and antibody … more
Multiple sclerosis: Gilenya reduced relapse rates, new MRI lesion counts, brain volume loss and disability progression in previously-treated patients with high disease activity
New analyses of pooled data from the FREEDOMS and FREEDOMS II trials have shown the consistent efficacy of Gilenya ( Fingolimod ) on four key measures of multiple sclerosis disease activity – reducing relapses, new MRI lesion counts, brain volume … more
Catheter venography: prevalence of extracranial venous narrowing in people with multiple sclerosis, their siblings, and unrelated healthy controls
Chronic cerebrospinal venous insufficiency has been proposed as a unique combination of extracranial venous blockages and haemodynamic flow abnormalities that occurs only in patients with multiple sclerosis and not in healthy people. Initial reports … more